Related Experiment Video

Updated: Jul 6, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

The use of daptomycin for Staphylococcus aureus infections in critical care medicine

Jeffrey Alder1

  • 1Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421, USA.

Critical Care Clinics
|March 26, 2008
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infections are a growing concern. Daptomycin offers a novel, effective alternative therapy for critical care patients due to its rapid bactericidal activity and safety profile.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Critical Care Medicine

Background:

  • Rising prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections.
  • Increasing vancomycin tolerance in MRSA strains poses a therapeutic challenge.
  • Nosocomial infections in critical care settings require novel treatment strategies.

Purpose of the Study:

  • To evaluate daptomycin as a viable alternative therapy for MRSA infections.
  • To highlight daptomycin's efficacy and safety in critical care settings.
  • To address the need for new treatments against resistant bacterial strains.

Main Methods:

  • Review of daptomycin's mechanism of action and existing clinical data.
  • Analysis of case studies on daptomycin for osteomyelitis and device-related infections.
  • Assessment of daptomycin's safety and efficacy in various infectious conditions.

Main Results:

  • Daptomycin exhibits a novel mechanism of action and rapid bactericidal activity.
  • No cross-resistance observed with other antibiotic classes.
  • Demonstrated efficacy in treating bacteremia, endocarditis, and complicated skin infections.

Conclusions:

  • Daptomycin is a potent lipopeptide antibiotic effective against MRSA.
  • Its rapid bactericidal action and safety profile make it suitable for critical care.
  • Daptomycin represents a promising alternative for challenging MRSA infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: